1 BTC
=
- USD
Nathan's Famous Inc
As of May 30, 2026 at 24:05 UTC
Chart
About Nathan's Famous Inc
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
Market Statistics
Trading Metrics
How to Buy NATH
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy NATH
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesSmithfield Foods reported better-than-expected Q4 results with adjusted EPS of 83 cents (vs. 68 cents consensus) and sales of $4.227 billion (up 7.0% YoY). The company announced a $450 million acquisition of Nathan's Famous at $102 per share, targeting close in H1 2026. For FY26, Smithfield projects total adjusted operating profit of $1.325-$1.475 billion with low-single-digit sales growth. Shares rose 4.13% to $24.45.
Investor rights law firm Halper Sadeh LLC is investigating four companies for potential federal securities law violations and breaches of fiduciary duties related to their merger transactions. The firm is seeking increased consideration for shareholders and additional disclosures regarding the proposed deals.
Monteverde & Associates PC, a class action law firm, is investigating four merger transactions: Penumbra's sale to Boston Scientific, RAPT Therapeutics' sale to GSK, Nathan's Famous' sale to Smithfield Foods, and Lisata Therapeutics' sale to Smithfield Foods. The firm is seeking shareholders who may have concerns about these deals.
The Schall Law Firm is investigating potential breaches of fiduciary duty by Nathan's Famous directors and management following the company's announcement of acquisition by Smithfield Foods for $102 per share on January 21, 2026. Investors are encouraged to contact the firm to discuss their rights.
Smithfield Foods announced an all-cash acquisition of Nathan's Famous for $450 million ($102 per share), eliminating expiration risk from their 2014 licensing agreement set to expire in 2032. The deal is expected to close in H1 2026 and deliver approximately $9 million in annual cost savings by year two, while being immediately accretive to adjusted diluted EPS.
